| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/15/2004 | EP0956304B1 Dendritic cell-specific antibodies |
| 12/15/2004 | EP0869816B1 Dry compositions comprising hydrophobic stabilizers |
| 12/15/2004 | CN1555488A Lymphatic endothelial cells materials and methods |
| 12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
| 12/15/2004 | CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 12/15/2004 | CN1555271A Interleukin-12 as a veterinary vaccine adjuvant |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1555254A 免疫原性脂质体组合物 Immunogenic liposome composition |
| 12/15/2004 | CN1554770A PCR process for preparing CpG DNA containing livestock and bird vaccine adjuvant |
| 12/15/2004 | CN1554766A Pig breeding and respiratory syndrome recombined adenovirus and vaccine |
| 12/15/2004 | CN1554764A Recombinant mva virus, and the use thereof |
| 12/15/2004 | CN1554751A CpG DNA gene engineering recombinant for livestock and bird vaccine adjuvant |
| 12/15/2004 | CN1554749A Structure of recombined T4 bacteriophage of expression infectious cysticercosis virus VP2 protein and its use |
| 12/15/2004 | CN1554664A Compounds and methods for diagnosis of tuberculosis |
| 12/15/2004 | CN1554446A Carrier transferred adjuvant antigen and its preparing method |
| 12/15/2004 | CN1554445A Process for preparing recombined T4 phage oil emulsion vaccine and its use |
| 12/15/2004 | CN1554444A Endothelial cell proliferation inhibitor and method of use |
| 12/15/2004 | CN1179973C HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 12/15/2004 | CN1179971C Adjuvent DC-chol, its liposome, preparation method and its use |
| 12/15/2004 | CN1179751C Foreign duck liver ichthyophthirius active vaccine and its preparation method |
| 12/14/2004 | US6831169 Hepatitis C virus vaccine |
| 12/14/2004 | US6830924 For anticarcinogenic drugs; kits |
| 12/14/2004 | US6830894 Compounds and methods for modulating claudin-mediated functions |
| 12/14/2004 | US6830883 Diagnosis/treatment/kits for anaemia/leukemia/immune deficiency diseases |
| 12/14/2004 | US6830748 Recombinant RSV virus expression systems and vaccines |
| 12/14/2004 | CA2285056C Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| 12/14/2004 | CA2235038C Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 12/14/2004 | CA2202499C Renibacterium salmoninarum vaccine and method for its preparation |
| 12/14/2004 | CA2104957C Redirection of cellular immunity by receptor chimeras |
| 12/13/2004 | CA2468651A1 Detection of neurodegenerative diseases |
| 12/09/2004 | WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 12/09/2004 | WO2004106384A1 Antibodies to masp-2 |
| 12/09/2004 | WO2004106367A2 Enterococcus antigens |
| 12/09/2004 | WO2004106366A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 12/09/2004 | WO2004105798A1 A PHARMACEUTICAL COMPOSITION COMPRISING A P2X7-RECEPTOR ANTAGONIST AND A TUMOUR NECROSIS FACTOR α |
| 12/09/2004 | WO2004105792A1 Composition against parvovirus infection |
| 12/09/2004 | WO2004105791A2 Recombinant anti-lhrh vaccines |
| 12/09/2004 | WO2004105729A2 Transdermal vaccine delivery device having coated microprotrusions |
| 12/09/2004 | WO2004105681A2 Cd4+ human papillomavirus (hpv) epitopes |
| 12/09/2004 | WO2004092209A3 S. pneumoniae antigens |
| 12/09/2004 | WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof |
| 12/09/2004 | WO2004074320A8 Therapeutic targets in cancer |
| 12/09/2004 | WO2004066961A3 Use of sendai virus as a human parainfluenza vaccine |
| 12/09/2004 | WO2004058183A3 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 12/09/2004 | WO2004050692A3 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 12/09/2004 | WO2004045551A3 Pharmaceutical composition |
| 12/09/2004 | WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 12/09/2004 | WO2004039337A3 Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization |
| 12/09/2004 | WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 12/09/2004 | WO2004032829A3 Immunostimulatory compositions and methods of stimulating an immune response |
| 12/09/2004 | WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 12/09/2004 | WO2004026238A3 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 12/09/2004 | WO2004006866A3 Antifungal therapeutic targets |
| 12/09/2004 | WO2003101283A3 Diagnostics markers for lung cancer |
| 12/09/2004 | WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 12/09/2004 | WO2003093478A9 Immunoconjugates for the treatment of tumours |
| 12/09/2004 | WO2003090687A8 Using heat shock proteins to increase immune response |
| 12/09/2004 | WO2003087131A3 Anti-her2 antibody variants |
| 12/09/2004 | WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | US20040250305 Adoptive transfer and uses thereof |
| 12/09/2004 | US20040249892 Secure header information for multi-content e-mail |
| 12/09/2004 | US20040249142 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 12/09/2004 | US20040249135 Using high energy electromagnetic waves to destroy viral, prion, bacterial, fungal and parasitic contaminants in immunoglobulin; antibody purity and immunotherapy |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249126 Chimeric antigen-specific t cell-activating polypeptides |
| 12/09/2004 | US20040249125 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248842 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/09/2004 | US20040248833 Therapeutic delivery compositions and methods of use thereof |
| 12/09/2004 | US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate |
| 12/09/2004 | US20040248802 Poly-Glu, Tyr for neuroprotective therapy |
| 12/09/2004 | US20040248799 Compositions and methods for treating cancer and hyperproliferative disorders |
| 12/09/2004 | US20040248798 Contraceptive methods and compositions related to proteasomal interference |
| 12/09/2004 | US20040248781 Therapeutic method for reducing angiogenesis |
| 12/09/2004 | US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators |
| 12/09/2004 | US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders |
| 12/09/2004 | US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections |
| 12/09/2004 | US20040248215 Immunoglobulin fusion comprising human chorionic gonadotropin component for use in treatment and prevention of viral infection and cell proliferative disorders |
| 12/09/2004 | US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders |
| 12/09/2004 | US20040248207 Sodium channel regulators and modulators |
| 12/09/2004 | US20040248201 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/09/2004 | US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering |
| 12/09/2004 | US20040248113 Expression vector comprising immunoglobulin sequences for treatment and prevention of infections and cell proliferative disorders; minigene vaccines; immunotherapy |
| 12/09/2004 | US20040248088 Novel g protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/09/2004 | US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor |
| 12/09/2004 | US20040247662 Systemic immune activation method using nucleic acid-lipid complexes |
| 12/09/2004 | US20040247661 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation |
| 12/09/2004 | US20040247623 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 12/09/2004 | US20040247622 Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae |
| 12/09/2004 | US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents |
| 12/09/2004 | US20040247620 Genetic transduction for improved exogenous gene expression of epothilones in a modified host cell |
| 12/09/2004 | US20040247617 Fusion antigen used as vaccine |
| 12/09/2004 | US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 12/09/2004 | US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination |
| 12/09/2004 | US20040247614 Lysine-acyetylated tat proteins of a human immunodeficiency virus; specifically binding antibodies; vaccination to inhibit transcriptional activation |